Retatrutide Explained: Triple-Hormone Metabolic Peptide, Evidence, Mechanism & Realistic Expectations
Retatrutide is an experimental triple-hormone receptor agonist peptide targeting GLP-1, GIP, and glucagon pathways. This comprehensive guide covers molecular mechanisms, clinical trial evidence, realistic expectations, and quality verification for laboratory research applications.

